Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 4/2011

Open Access 01-08-2011 | Research

The relationship between inotrope exposure, six-hour postoperative physiological variables, hospital mortality and renal dysfunction in patients undergoing cardiac surgery

Authors: Jason Shahin, Benoit deVarennes, Chun Wing Tse, Dan-Alexandru Amarica, Sandra Dial

Published in: Critical Care | Issue 4/2011

Login to get access

Abstract

Introduction

Acute haemodynamic complications are common after cardiac surgery and optimal perioperative use of inotropic agents, typically guided by haemodynamic variables, remains controversial. The aim of this study was to examine the relationship of inotrope use to hospital mortality and renal dysfunction.

Material and methods

A retrospective cohort study of 1,326 cardiac surgery patients was carried out at two university-affiliated ICUs. Multivariable logistic regression analysis and propensity matching were performed to evaluate whether inotrope exposure was independently associated with mortality and renal dysfunction.

Results

Patients exposed to inotropes had a higher mortality rate than those not exposed. After adjusting for differences in Parsonnet score, left ventricular ejection fraction, perioperative intraaortic balloon pump use, bypass time, reoperation and cardiac index, inotrope exposure appeared to be independently associated with increased hospital mortality (adjusted odds ratio (OR) 2.3, 95% confidence interval (95% CI) 1.2 to 4.5) and renal dysfunction (adjusted OR 2.7, 95% CI 1.5 to 4.6). A propensity score-matched analysis similarly demonstrated that death and renal dysfunction were significantly more likely to occur in patients exposed to inotropes (P = 0.01).

Conclusions

Postoperative inotrope exposure was independently associated with worse outcomes in this cohort study. Further research is needed to better elucidate the appropriate use of inotropes in cardiac surgery.
Appendix
Available only for authorised users
Literature
1.
Ahmed I, House CM, Nelson WB: Predictors of inotrope use in patients undergoing concomitant coronary artery bypass graft (CABG) and aortic valve replacement (AVR) surgeries at separation from cardiopulmonary bypass (CPB). J Cardiothorac Surg. 2009, 4: 24-10.1186/1749-8090-4-24.PubMedPubMedCentralCrossRef
2.
Gillies M, Bellomo R, Doolan L, Buxton B: Bench-to-bedside review: Inotropic drug therapy after adult cardiac surgery: a systematic literature review. Crit Care. 2005, 9: 266-279. 10.1186/cc3024.PubMedPubMedCentralCrossRef
3.
St André AC, DelRossi A: Hemodynamic management of patients in the first 24 hours after cardiac surgery. Crit Care Med. 2005, 33: 2082-2093. 10.1097/01.CCM.0000178355.96817.81.PubMedCrossRef
4.
Kastrup M, Markewitz A, Spies C, Carl M, Erb J, Grosse J, Schirmer U: Current practice of hemodynamic monitoring and vasopressor and inotropic therapy in post-operative cardiac surgery patients in Germany: results from a postal survey. Acta Anaesthesiol Scand. 2007, 51: 347-358. 10.1111/j.1399-6576.2006.01190.x.PubMedCrossRef
5.
Butterworth JF: Dobutamine: Too dangerous for routine administration?. Anesthesiology. 2008, 108: 973-974. 10.1097/ALN.0b013e318172fb98.PubMedCrossRef
6.
Hernandez AF, Li S, Dokholyan RS, O'Brien SM, Ferguson TB, Peterson ED: Variation in perioperative vasoactive therapy in cardiovascular surgical care: data from the Society of Thoracic Surgeons. Am Heart J. 2009, 158: 47-52. 10.1016/j.ahj.2009.05.014.PubMedCrossRef
7.
Parissis JT, Rafouli-Stergiou P, Stasinos V, Psarogiannakopoulos P, Mebazaa A: Inotropes in cardiac patients: update 2011. Curr Opin Crit Care. 2010, 16: 432-441. 10.1097/MCC.0b013e32833e10fb.PubMedCrossRef
8.
Fellahi JL, Parienti JJ, Hanouz JL, Plaud B, Riou B, Ouattara A: Perioperative use of dobutamine in cardiac surgery and adverse cardiac outcome: propensity-adjusted analyses. Anesthesiology. 2008, 108: 979-987. 10.1097/ALN.0b013e318173026f.PubMedCrossRef
9.
Thackray S, Easthaugh J, Freemantle N, Cleland JG: The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure: a meta-regression analysis. Eur J Heart Fail. 2002, 4: 515-529. 10.1016/S1388-9842(02)00041-7.PubMedCrossRef
10.
Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M, Early Goal-Directed Therapy Collaborative Group: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001, 345: 1368-1377. 10.1056/NEJMoa010307.PubMedCrossRef
11.
Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A, Acute Kidney Injury Network: Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007, 11: R31-10.1186/cc5713.PubMedPubMedCentralCrossRef
12.
Fleming GA, Murray KT, Yu C, Byrne JG, Greelish JP, Petracek MR, Hoff SJ, Ball SK, Brown NJ, Pretorius M: Milrinone use is associated with postoperative atrial fibrillation after cardiac surgery. Circulation. 2008, 118: 1619-1625. 10.1161/CIRCULATIONAHA.108.790162.PubMedPubMedCentralCrossRef
13.
Cohn JN, Goldstein SO, Greenberg BH, Lorell BH, Bourge RC, Jaski BE, Gottlieb SO, McGrew F, DeMets DL, White BG: A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators. N Engl J Med. 1998, 339: 1810-1816. 10.1056/NEJM199812173392503.PubMedCrossRef
14.
Cuffe MS, Califf RM, Adams KF, Benza R, Bourge R, Colucci WS, Massie BM, O'Connor CM, Pina I, Quigg R, Silver MA, Gheorghiade M, Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Investigators: Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA. 2002, 287: 1541-1547. 10.1001/jama.287.12.1541.PubMedCrossRef
15.
Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM, Hendrix GH, Bommer WJ, Elkayam U, Kukin ML, Mallis GI, Sollano JA, Shannon J, Tandon PK, DeMets DL, the PROMISE Study Research Group: Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med. 1991, 325: 1468-1475. 10.1056/NEJM199111213252103.PubMedCrossRef
16.
Mebazaa A, Nieminen MS, Packer M, Cohen-Solal A, Kleber FX, Pocock SJ, Thakkar R, Padley RJ, Põder P, Kivikko M, SURVIVE Investigators: Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. JAMA. 2007, 297: 1883-1891. 10.1001/jama.297.17.1883.PubMedCrossRef
17.
Mebazaa A, Parissis J, Porcher R, Gayat E, Nikolaou M, Boas FV, Delgado JF, Follath F: Short-term survival by treatment among patients hospitalized with acute heart failure: the global ALARM-HF registry using propensity scoring methods. Intensive Care Med. 2011, 37: 290-301. 10.1007/s00134-010-2073-4.PubMedCrossRef
18.
Giglio MT, Marucci M, Testini M, Brienza N: Goal-directed haemodynamic therapy and gastrointestinal complications in major surgery: a meta-analysis of randomized controlled trials. Br J Anaesth. 2009, 103: 637-646. 10.1093/bja/aep279.PubMedCrossRef
19.
Boyd O, Grounds RM, Bennett ED: A randomized clinical trial of the effect of deliberate perioperative increase of oxygen delivery on mortality in high-risk surgical patients. JAMA. 1993, 270: 2699-2707. 10.1001/jama.270.22.2699.PubMedCrossRef
20.
Grocott MPW, Hamilton MA, Bennett ED, Harrison D, Rowan K: Perioperative increase in global blood flow to explicit defined goals and outcomes following surgery. Cochrane Database Syst Rev. 2006, 2: CD004082-
21.
Kapoor PM, Kakani M, Chowdhury U, Choudhury M, Kiran U: Early goal-directed therapy in moderate to high-risk cardiac surgery patients. Ann Card Anaesth. 2008, 11: 27-34. 10.4103/0971-9784.38446.PubMedCrossRef
22.
McKendry M, McGloin H, Saberi D, Caudwell L, Brady AR, Singer M: Randomised controlled trial assessing the impact of a nurse delivered, flow monitored protocol for optimisation of circulatory status after cardiac surgery. BMJ. 2004, 329: 258-10.1136/bmj.38156.767118.7C.PubMedPubMedCentralCrossRef
23.
Pölönen P, Ruokonen E, Hippeläinen M, Pöyhönen M, Takala J: A prospective, randomized study of goal-oriented hemodynamic therapy in cardiac surgical patients. Anesth Analg. 2000, 90: 1052-1059. 10.1097/00000539-200005000-00010.PubMedCrossRef
24.
Goepfert MS, Reuter DA, Akyol D, Lamm P, Kilger E, Goetz AE: Goal-directed fluid management reduces vasopressor and catecholamine use in cardiac surgery patients. Intensive Care Med. 2007, 33: 96-103. 10.1007/s00134-006-0404-2.PubMedCrossRef
25.
Singer M: Catecholamine treatment for shock-equally good or bad?. Lancet. 2007, 370: 636-637. 10.1016/S0140-6736(07)61317-8.PubMedCrossRef
26.
Bastien O, Vallet B, French Study Group AGIR: French multicentre survey on the use of inotropes after cardiac surgery. Crit Care. 2005, 9: 241-242. 10.1186/cc3482.PubMedPubMedCentralCrossRef
Metadata
Title
The relationship between inotrope exposure, six-hour postoperative physiological variables, hospital mortality and renal dysfunction in patients undergoing cardiac surgery
Authors
Jason Shahin
Benoit deVarennes
Chun Wing Tse
Dan-Alexandru Amarica
Sandra Dial
Publication date
01-08-2011
Publisher
BioMed Central
Published in
Critical Care / Issue 4/2011
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc10302

Other articles of this Issue 4/2011

Critical Care 4/2011 Go to the issue

Review

Bench-to-bedside review: Ventilation-induced renal injury through systemic mediator release - just theory or a causal relationship?

Research

O2 delivery and CO2 production during cardiopulmonary bypass as determinants of acute kidney injury: time for a goal-directed perfusion management?

Research

Hemodynamic monitoring and management in patients undergoing high risk surgery: a survey among North American and European anesthesiologists

Research

Statin pre-treatment is associated with lower platelet activity and favorable outcome in patients with acute non-cardio-embolic ischemic stroke

Research

High mixed venous oxygen saturation levels do not exclude fluid responsiveness in critically ill septic patients

Viewpoint

Working with capacity limitations: operations management in critical care